Core Viewpoint - Suzhou Mediston Medical Technology Co., Ltd. has completed the registration of changes in its business scope, expanding into the development and sales of intelligent robots and drones, which indicates a strategic shift towards advanced technology sectors [1]. Group 1: Business Scope Changes - The company held a temporary shareholders' meeting on June 2025, where it approved the proposal to expand its business scope to include "research and development of intelligent robots; manufacturing and sales of service consumer robots; sales of intelligent unmanned aerial vehicles" [1]. - The company has received a new business license from the Suzhou Data Bureau reflecting these changes [1]. Group 2: Company Information - The company is registered as a joint-stock company with a registered capital of 306.282731 million yuan, established on August 14, 2009 [1]. - The company's address is located at 222 Gui Jia Xiang, Suzhou Industrial Park, and its legal representative is Weng Kang [1]. Group 3: Business Operations - The company’s original business scope includes the research and development of medical devices, computer software and hardware, and communication technology, among others [1]. - The company is also involved in the production and sales of various classes of medical devices, as well as providing technical services and consulting [1].

Core Viewpoint - The company is addressing significant financial losses and proposing measures to enhance its operational efficiency and expand its business scope in response to the challenges faced in the photovoltaic industry [4][5][7]. Group 1: Financial Situation - As of December 31, 2024, the company's undistributed profits amounted to -238,824,801.42 yuan, with unremedied losses exceeding one-third of the paid-in capital of 306,282,731.00 yuan [4]. - The primary reason for the losses is attributed to a mismatch in supply and demand within the photovoltaic industry, leading to a decline in gross profit margins [4]. Group 2: Proposed Measures - The company plans to enhance cost optimization and expense control after divesting from the photovoltaic business, focusing on improving profitability [5]. - The strategy includes advancing medical information technology towards platformization, regionalization, and intelligence, while exploring new business opportunities through innovative technology applications [5]. Group 3: Business Scope Expansion - The company proposes to expand its business scope to include the research and development of intelligent robots, manufacturing and sales of service consumer robots, and sales of intelligent unmanned aerial vehicles [6][7]. - The changes in the business scope will require approval from the market supervision administration and will be reflected in the company's articles of association [7].

Core Viewpoint - The company, Suzhou Mediston Medical Technology Co., Ltd., is planning to expand its business scope to include the research and development of intelligent robots, manufacturing and sales of service consumer robots, and sales of intelligent unmanned aerial vehicles, in order to accelerate its innovative business development [1][2]. Group 1: Business Scope Changes - The company intends to add the following activities to its business scope: research and development of intelligent robots, manufacturing of service consumer robots, sales of service consumer robots, and sales of intelligent unmanned aerial vehicles [1]. - The previous business scope included the research and development of medical devices, computer software and hardware, medical robot navigation systems, minimally invasive surgical platform systems, and mechatronic products, among others [1]. - The updated business scope will still encompass the original activities while incorporating the new areas of focus [1]. Group 2: Company Charter Revision - The company will revise its Articles of Association to reflect the changes in its business scope [1]. - Other provisions in the Articles of Association will remain unchanged [1]. - The proposed changes will require approval from the shareholders' meeting and must be registered with the market supervision administration [2].